<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000663013"><TermName>carboplatin-paclitaxel-bevacizumab regimen</TermName><TermPronunciation>(KAR-boh-pla-tin-PA-klih-TAK-sil-beh-vuh-SIH-zoo-mab REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>A chemotherapy combination used to treat advanced, nonsquamous non-small cell lung cancer.  It includes the drugs carboplatin, paclitaxel (Taxol), and bevacizumab. Also called carboplatin-Taxol-bevacizumab regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000725896" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;carboplatin-paclitaxel-bevacizumab regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000725897" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen carboplatino-paclitaxel-bevacizumab&quot;" language="es" id="_4"/><SpanishTermName>régimen carboplatino-paclitaxel-bevacizumab</SpanishTermName><SpanishTermDefinition><DefinitionText>Quimioterapia combinada que se usa para tratar el cáncer de pulmón de células no escamosas no pequeñas en estadio avanzado. Incluye los medicamentos carboplatino, paclitaxel (Taxol) y bevacizumab. También se llama régimen carboplatino-Taxol-bevacizumab.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-05-26</DateFirstPublished></GlossaryTerm>
